Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene R Bleecker

Showing results (1-10 of 358) with videos related to

Pageof 36
Sort By:
Chest|August 11, 2004
Similarities and differences in asthma and COPD. The Dutch hypothesisEugene R Bleecker
The Journal of Allergy and Clinical Immunology|June 24, 2019
Strength in numbers: The quest for asthma genesDonata Vercelli, Eugene R Bleecker
Current Opinion in Pharmacology|July 22, 2010
Pharmacogenetics of asthmaRodolfo M Pascual, Eugene R Bleecker
Clinics in Chest Medicine|March 18, 2006
Pharmacogenetics of asthma: where are we now?Michael J Larj, Eugene R Bleecker
The Journal of Allergy and Clinical Immunology|December 5, 2002
Effects of beta2-agonists on airway tone and bronchial responsivenessMichael J Larj, Eugene R Bleecker
The Lancet. Respiratory Medicine|January 28, 2014
Asthma heterogeneity and severity-why is comprehensive phenotyping important?Wendy C Moore, Eugene R Bleecker
Chest|August 11, 2004
Therapeutic responses in asthma and COPD. CorticosteroidsMichael J Larj, Eugene R Bleecker
Immunology and Allergy Clinics of North America|November 1, 2005
Asthma pharmacogenomicsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
Physiological Genomics|March 1, 2007
A Roadmap to functional genomicsRaymond B Penn, Victor E Ortega, Eugene R Bleecker
Pharmacogenomics|February 29, 2008
Clinical consequences of ADRbeta2 polymorphismsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
Pageof 36

Showing results (1-10 of 358) with videos related to

Sort By:
Pageof 36
Chest|August 11, 2004
Similarities and differences in asthma and COPD. The Dutch hypothesisEugene R Bleecker
The Journal of Allergy and Clinical Immunology|June 24, 2019
Strength in numbers: The quest for asthma genesDonata Vercelli, Eugene R Bleecker
Current Opinion in Pharmacology|July 22, 2010
Pharmacogenetics of asthmaRodolfo M Pascual, Eugene R Bleecker
Clinics in Chest Medicine|March 18, 2006
Pharmacogenetics of asthma: where are we now?Michael J Larj, Eugene R Bleecker
The Journal of Allergy and Clinical Immunology|December 5, 2002
Effects of beta2-agonists on airway tone and bronchial responsivenessMichael J Larj, Eugene R Bleecker
The Lancet. Respiratory Medicine|January 28, 2014
Asthma heterogeneity and severity-why is comprehensive phenotyping important?Wendy C Moore, Eugene R Bleecker
Chest|August 11, 2004
Therapeutic responses in asthma and COPD. CorticosteroidsMichael J Larj, Eugene R Bleecker
Immunology and Allergy Clinics of North America|November 1, 2005
Asthma pharmacogenomicsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
Physiological Genomics|March 1, 2007
A Roadmap to functional genomicsRaymond B Penn, Victor E Ortega, Eugene R Bleecker
Pharmacogenomics|February 29, 2008
Clinical consequences of ADRbeta2 polymorphismsGregory A Hawkins, Scott T Weiss, Eugene R Bleecker
Pageof 36